Pradaxa 110 mg capsules

Pradaxa is a widely used anticoagulant medication containing dabigatran etexilate, primarily used to prevent strokes and blood clots. The brand was developed and is owned by Boehringer Ingelheim, a major German pharmaceutical company founded in 1885 by Albert Boehringer.

While the main research and production facilities are based in Germany, specifically in Ingelheim am Rhein and Biberach, the pharmaceutical is distributed globally. In Spain and other international markets, it is directly managed through regional subsidiaries of the Boehringer Ingelheim group. The company remains one of the largest private pharmaceutical firms in the world, maintaining its independence and headquarters in Germany.